Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. company information, Employees & Contact Information

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biopharmaceutical company whose proprietary INTASYL siRNA technology makes our bodies’ immune cells more effective in killing tumor cells. INTASYL is the only self-delivering siRNA technology focused on immuno-oncology therapeutics. INTASYL drugs precisely target specific proteins that reduce the body’s ability to fight cancer, without the need for specialized formulations or drug delivery systems. Phio was co-founded by Nobel Laureate Craig Mello, who was awarded the Nobel prize in 2006 for his discovery of RNAi, which has broad therapeutic applications. Our founders opened up a whole new field of biology when they discovered RNAi, and we continue their pioneering efforts today through our work with INTASYL. We’re committed to discovering and developing innovative cancer treatments for patients, creating new pathways for a cancer-free future. For additional information, visit the Company's website, www.phiopharma.com. #INTASYL #siRNA #RNAi #Phio #immunooncology

Company Details

Employees
15
Founded
-
Address
411 Swedeland Rd,
Phone
5083665877
Email
ad****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
King of Prussia, Pennsylvania
Looking for a particular Phio Pharmaceuticals Corp. employee's phone or email?

Phio Pharmaceuticals Corp. Questions

News

Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort - Newsfile

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort Newsfile

Phio Pharmaceuticals Advances Cancer Drug Production with Strategic US Manufacturing Partnership - Stock Titan

Phio Pharmaceuticals Advances Cancer Drug Production with Strategic US Manufacturing Partnership Stock Titan

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - FinancialContent

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series FinancialContent

Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762 - Yahoo Finance

Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762 Yahoo Finance

Phio Pharmaceuticals Announces Reverse Stock Split - Newsfile

Phio Pharmaceuticals Announces Reverse Stock Split Newsfile

Top Phio Pharmaceuticals Corp. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant